Patent US4235897A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4235897A Expired / Lapsed US ⏱️ 0.0 years remaining

Benzodiazepine derivatives and pharmaceutical compositions thereof

Assignee: Sanofi SA
•
Filing: 1979-02-21
•
Granted: 1980-11-25
•
Expires: 1999-02-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to benzodiazepine compounds of the formula: <IMAGE> wherein R5 is C1-C4 alkyl, R3 is C1-C4 alkyl, and R4 is selected from Cl and F, and medicaments containing such benzodizepine compounds.

Inventors

  • 👤 Henri Demarne
  • 👤 Andre Hallot

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 12:40
CPC Classifications
C; C07; C07D; C07D243/00; C07D243/06; C07D243/10; C07D243/14; C07D243/16; C07D243/18; C07D243/24; A; A61; A61P; A61P21/00; A61P21/02; A61P25/00; A61P25/08; A61P25/20; A61P25/26

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 33 words
A benzodiazepine compound of the formula: ##STR7## wherein: R 5 is C 1 --C 4 alkyl; R 3 is C 1 --C 4 alkyl; and R 4 is selected from Cl and F.
Claim 2
Dependent Claim 33 words
A benzodiazepine compound of the formula: ##STR7## wherein: R 5 is C 1 --C 4 alkyl; R 3 is C 1 --C 4 alkyl; and R 4 is selected from Cl and F.
Claim 3
Dependent Claim 54 words
A pharmaceutical composition useful for the treatment of neuropsychic disturbances, characterized in that it contains a compound as defined in claim 1 as active ingredient in association with a pharmaceutically acceptable carrier, and is administered in such a manner that the patient receives from 2 to 100 mg per day of the active ingredient.
Claim 4
Dependent Claim 28 words
A pharmaceutical composition useful for the treatment of anxiety, comprising an effective amount of a compound as defined in claim 1 in association with a pharmaceutically acceptable carrier.
Claim 5
Dependent Claim 22 words
A benzodiazepine compound as defined in claim 1, wherein R 5 is methyl; R 3 is ethyl; and R 4 is chloro.
Claim 6
Dependent Claim 22 words
A benzodiazepine compound as defined in claim 1, wherein R 5 is methyl; R 3 is ethyl; and R 4 is fluoro.

References Cited (Backward Citations)

US3136815A Cited
US3236838A Cited
FR1497456A Cited
US3516988A Cited
USRE28315E Cited
US3812103A Cited
US3718646A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-11-25 1984-05-26 1984-11-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-11-25 1988-05-26 1988-11-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-11-25 1992-05-26 1992-11-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag